www.nature.com/scientificreports

OPEN

received: 09 September 2016
accepted: 27 January 2017
Published: 02 March 2017

Latent TGF-β binding protein 2
and 4 have essential overlapping
functions in microfibril
development
Yusuke Fujikawa1,2, Hideyuki Yoshida1,3, Tadashi Inoue1,4, Tetsuya Ohbayashi5,
Kazuo Noda6, Harald von Melchner7, Toshiji Iwasaka2, Ichiro Shiojima2, Tomoya O. Akama1 &Tomoyuki Nakamura1
Microfibrils are exracellular matrix components necessary for elastic fiber assembly and for suspending
lenses. We previously reported that latent TGF-β binding protein 2 (LTBP-2), a microfibril-associatedprotein, is required for forming stable microfibril bundles in ciliary zonules. However, it was notunderstood why Ltbp2 null mice only showed an eye-specific phenotype, whereas LTBP-2 is abundantly
expressed in other tissues containing microfibrils in wild type mice. Here, we show that LTBP-4,
another microfibril-associated protein, compensates for the loss of LTBP-2 in microfibril formation.
Ltbp2/4S double knockout (DKO) mice showed increased lethality due to emphysema, which wasmuch more severe than that found in Ltbp4S null mice. Elastic fibers in the lungs of Ltbp2/4S DKO
mice were severely disorganized and fragmented. Cultured mouse embryonic fibroblasts (MEFs) from
Ltbp2/4S DKO embryos developed reduced microfibril meshwork in serum-free conditions, whereas the
microfibril formation was restored by the addition of either recombinant LTBP-2 or -4. Finally, ectopic
expression of LTBP-4 in the whole body restored ciliary zonule microfibril bundles in the eyes of Ltbp2
null mice. These data suggest that LTBP-2 and -4 have critical overlapping functions in forming therobust structure of microfibrils in vitro and in vivo.
Microfibrils are abundantly distributed extracellular matrix (ECM) components. Some of these serve as a scaffold
for tropoelastin deposition to form elastic fibers, whereas others constitute a structural unit without elastin, as
in ciliary zonules1,2. Microfibrils are composed of homopolymers of fibrillin-1 and -2 together with associating proteins such as latent TGF-β​binding proteins (LTBPs) and microfibril-associated glycoproteins (MAGPs).
Fibrillin-1 and -2 are the defective gene products in Marfan syndrome and congenital contractural arachnodactily, respectively. Microfibrils are organized into various architectures to accommodate the mechanical requirements of different tissues. For example, ciliary zonules in the eye are composed of a thick bundle of microfibrils
that conduct tension between the lens and ciliary bodies, whereas in the skin, loosely assembled microfibrils
extend from the epidermal basement membrane to the reticular dermis to connect with dermal elastic fibers3. In
arteries, elastic fibers form a lamellar structure to constitute elastic lamellae. Therefore, microfibrils that provide
scaffolds for elastin deposition should also be configured as a lamellar meshwork. The factors that determine thearchitectures of microfibrils between different tissues remain poorly understood, although microfibril-associating
molecules likely play an important role.
LTBPs are multi-domain ECM proteins with molecular masses of 150–220 kDa which share structural homology with fibrillins4–6. Among the four LTBPs, LTBP-1 and -3 play major roles in regulating TGF-β​ bioavailability
1

Department of Pharmacology, Kansai Medical University, Osaka, 573-1010, Japan. 2Department of Cardiology,
Kansai Medical University, Osaka, 573-1010, Japan. 3Department of Ophthalmology, Kansai Medical University,
Osaka, 753-1010, Japan. 4Department of Plastic and Reconstructive Surgery, Kansai Medical University, Osaka,
573-1010, Japan. 5Division of Laboratory Animal Science, Research Center for Bioscience and Technology, Tottori
University Graduate School of Medical Sciences, Yonago, Tottori, 683-8503, Japan. 6Department of Plastic andReconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. 7Departmentof Molecular Hematology, University of Frankfurt Medical School, Frankfurt am Main, 60590, Germany.
Correspondence and requests for materials should be addressed to T.N. (email: nakamtom@hirakata.kmu.ac.jp)
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

1

www.nature.com/scientificreports/

Figure 1. Expression of genes of the LTBP family in mouse tissues. Gene expression of Ltbp1, 2, 3 and 4 andGapdh in ciliary bodies, aorta and lung tissues from wild type (+​/+​) and Ltbp2−/− (−​/−​) mice was analyzed
using RT-PCR. Expression of Ltbp4 was hardly detected in ciliary body tissues from either wild type or Ltbp2−/−
mice.
by tethering TGF-β​propeptide (latency-associated peptide or LAP) that binds to mature TGF-β​, thus facilitating the secretion, storage in the ECM, and activation of TGF-β​. These LTBPs associate with the LAPs of all
three TGF-β​isoforms; however, LTBP-4 only interacts with TGF-β​1-LAP and does so very inefficiently, whereas
LTBP-2 does not interact with any TGF-β​-LAP complexes4–6. Therefore, the primary roles of LTBP-2 and -4 areconsidered TGF-β​-independent.
There have been several reports of human patients with homozygous LTBP2 null mutations, who suffer fromglaucoma with high intraocular pressure (IOP), ectopia lentis, megalocornea and microspherophakia7–12. We
previously showed that Ltbp2 null mice exhibit fragmented ciliary zonules leading to lens dislocation13. Using cell
culture and organ explant culture, we demonstrated that LTBP-2 is required for the formation of stable microfibril
bundles in ciliary zonules. However, it is not understood why patients with LTBP2 mutations or Ltbp2 null mice
only show eye-related phenotypes, whereas LTBP-2 is abundantly expressed in other tissues such as lungs andarteries that are rich in elastic fibers in wild type mice14–16.
LTBP-4 plays a major role in elastic fiber development. Homozygous LTBP4 mutations in humans werereported to cause cutis laxa type 2, a condition characterized by loose skin and emphysema17. Mice lacking
LTBP-4S, which is the major splicing form expressed in the lungs and intestine, exhibit severely fragmented
elastic fibers resulting in emphysematous lungs and stiff arteries18. We previously demonstrated that LTBP-4
promotes elastin deposition onto microfibrils through interaction of LTBP-4 with fibulin-5 and fibulin-5 withelastin19. However, any role of LTBP-4 in microfibril development is not known.
Here, we show overlapping functions of LTBP-2 and -4 in microfibril development. While Ltbp4S null miceshow emphysematous lungs and Ltbp2 null mice have no phenotype in organs other than the eyes, Ltbp2/4S
DKO mice exhibit a much more severe form of emphysema than that found in Ltbp4S null mice, which was
associated with increased mortality. The abrogated microfibril formation observed in Ltbp2/4S DKO MEFs cultured in serum-free conditions was rescued by the addition of either recombinant LTBP-2 or -4. In addition,ectopic expression of LTBP-4 in Ltbp2 null mouse eyes restored stable ciliary zonules. This novel function of
LTBP-4 in the development of microfibrils, at least in part, explains the absence of an extra-ocular phenotype in
LTBP2-deficient patients.

Results

Ltbp1 and 3, but not 4, mRNA was abundantly expressed in the ciliary bodies of wild type andLtbp2 null mice. Assuming that other LTBPs may compensate for the loss of LTBP-2 in stable microfibril

formation in tissues other than the eyes in Ltbp2 null mice, we analyzed the expression of Ltbp1, 2, 3, and 4 mRNAin the lungs, aortae, and ciliary bodies of wild type and Ltbp2 null mice using RT-PCR (Fig. 1). Ltbp1 and 3 wereexpressed in ciliary bodies and in other tissues in both wild type and Ltbp2 null mice, indicating that LTBP-1
and -3 were not able to compensate for the loss of LTBP-2. On the other hand, only a trace amount of Ltbp4 was
expressed in ciliary bodies, while it was abundantly expressed in the lungs and aortae, suggesting that LTBP-4 isa candidate molecule that could substitute for LTBP-2 to enable stable microfibril formation in tissues other thanthe eyes.
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

2

www.nature.com/scientificreports/

Figure 2. Survival rate of Ltbp2/4S mutant mice after birth. Starting from postnatal day 7 (P7), pups of wild
type, Ltbp4S−/− mice (produced by intercross of Ltbp4S+/− mice), Ltbp2−/− mice, and Ltbp2−/−; Ltbp4S−/− mice
(produced by intercross of Ltbp2−/− and Ltbp4S+/− mice) were evaluated for survival every week. *P <​  0.05,
determined by log-rank test.

Ltbp2/4S DKO mice had a higher mortality rate than that of Ltbp2 or 4S single KO mice.

Toassess whether LTBP-4 compensated for the loss of LTBP-2 in Ltbp2 null mice, we generated Ltbp2/4S DKO
mice. Since Ltbp2 null mice do not have any embryonic and reproductive abnormalities, we set up an Ltbp2−/−;
Ltbp4S+/− intercross to produce Ltbp2−/−; Ltbp4S−/− (Ltbp2/4S DKO) mice. Approximately 50% of Ltbp2/4S DKO
mice did not survive until the weaning period (4 weeks after birth). We evaluated the survival rate of Ltbp2/4S
DKO mice along with that of other genotypes in every week after birth (Supplementary Fig. S1a). Mice having a
genotype of either Ltbp2−/−; Ltbp4S+/+ or Ltbp2−/−; Ltbp4S+/− did not show a major decrease in survival rate at 4
weeks after birth, and most of the Ltbp2/4S DKO mice survived by 3 weeks after birth. However, the survival rateof DKO mice suddenly decreased by 50% at 4 weeks after birth (Fig. 2). Dabovic et al., reported that Ltbp4S nullmice show moderate lethality by 4 weeks after birth20. However, we analyzed the survival rate of Ltbp4S null miceat 4 weeks after birth and did not observe lethality (Fig. 2 and Supplementary Fig. S1b), indicating that juvenile
lethality we found in our mutant mice was caused by the cooperative effect of LTBP-2 and LTBP-4 deficiencies.
Interestingly, 70% of the Ltbp2/4S DKO mice that survived for 4 weeks after birth remained alive for 2 months ormore after birth, suggesting a major critical period for survival of Ltbp2/4S DKO mice was between 3 weeks and4 weeks after birth.

Vascular impairment in Ltbp2/4S DKO mice was similar to that found in Ltbp4S null mice.

To
understand the cause of increased lethality in Ltbp2/4S DKO mice, we analyzed the physical characteristics andtissue abnormalities in 8-week-old mice of all genotypes, including Ltbp2/4S DKO mice. Systolic, diastolic, andmean blood pressure were not different between the genotypes. However, the body weight of Ltbp2/4S DKO mice
was significantly decreased compared with that of mice of other genotypes (Supplementary Fig. S2).
We reported that Ltbp4S null mice show aortic tortuosity at day 5 after birth19. We confirmed that neonatal
mice of both Ltbp4S null and Ltbp2/4S DKO genotypes showed tortuous aorta (Supplementary Fig. S3a), althoughaortic tortuosity became less obvious in adult animals (8-week-old, Supplementary Fig. S3b). Mice with both wild
type and Ltbp2 null genotypes showed no evident aortic abnormalities at the neonatal stage or the adult stage.
Although microfibril defects in arteries were expected to result in ascending aortic aneurysm as occurs in Marfan
syndrome caused by fibrillin-1 mutations, Ltbp2/4S DKO mice did not show apparent aneurysms.

Ltbp2/4S DKO mice show more severe emphysema than that found in Ltbp4S null mice. Ltbp4S

null mice were reported to develop pulmonary emphysema18,21. Macroscopic examination confirmed obvious
emphysema in Ltbp4S mice, and notably, Ltbp2/4S DKO mice showed a more severe form of emphysema thanthat found in Ltbp4S null mice (Fig. 3). Remarkably large terminal air sacs, indicative of disruption of alveolar
walls, were observed in the lungs of Ltbp2/4S DKO mice (Fig. 3). We then conducted histological analysis of
the lungs of wild type and mutant mice at different developmental stages. Lung development in mice proceeds
after birth with terminal air sac septation and alveolarization occurring between P0.5 and P2120. Before birth,lung morphology was indistinguishable among wild type, Ltbp2 null, and Ltbp4S null mice, whereas the lungs of
Ltbp2/4S DKO mouse had larger terminal air sacs, indicating a septation defect (Fig. 4a). At 8 weeks after birth,the lungs of wild type and Ltbp2 null mice showed normal development. However, airspace enlargement wasobserved in the lungs of adult Ltbp4S null mice, and these defects were even more evident in the lung of Ltbp2/4S
DKO mice (Fig. 4b).
Degradation or impairment of elastic fibers is a major cause of emphysema22. Thus, we next analyzed elastic
fibers in lung ECM, using electron microscopy. Elastic fibers were visualized by tannic acid staining. Continuous
thick elastic fibers were observed along the alveolar walls in wild type and Ltbp2 null mice (Fig. 4c). These tannic
acid-positive elastic fibers were fragmented as dot-like deposits in the lungs of Ltbp4S null mice (Fig. 4c). We also
observed microfibril bundles devoid of elastin deposition in Ltbp4S null tissues, as previously reported21, indicating an essential function of LTBP-4 in mediating the proper assembly of elastin on microfibrils19. In Ltbp2/4S
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

3

www.nature.com/scientificreports/

Figure 3. Gross morphology of Ltbp2/4S mutant lung in 8-week-old mice. Mild and severe emphysematous
phenotypes were observed in Ltbp4S−/− and Ltbp2/4S DKO mice, respectively.

DKO lungs, we only observed smaller pieces of fragmented elastic fibers than in Ltbp4S null lung (Fig. 4c). Unlike
Ltbp4S null tissue, we did not observe microfibril bundles without elastin deposition in Ltbp2/4S DKO tissue.
Immunofluorescent staining of adult lungs using an anti-fibrillin-1 antibody revealed microfibrils in the wall ofalveoli and blood vessels (Fig. 4d). Fibrillin microfibrils in the lungs of Ltbp2/4S DKO mice appeared discontinuous compared with those in lung tissues of the other genotypes. These results suggest that the severe emphysematous phenotype observed in Ltbp2/4S DKO mice could be attributable to degenerated elastic fibers with inefficient
formation of bundled microfibrils, in addition to the terminal air sac septation defect.

Expression of elastogenic genes was enhanced at 3 weeks after birth but largely reduced at 8
weeks after birth in Ltbp2/4S DKO mouse lung tissue. Severe disruption of elastic fibers and alve-olar walls in Ltbp2/4S DKO mouse lungs suggested impaired elastogenesis and/or an increase in elastolysis inthese tissues. Therefore, we analyzed the mRNA expression level of the genes involved in elastic fiber formation and degradation in the lungs at different developmental stages. In neonatal lungs, the expression levels of
ECM-related genes were not drastically changed, and the differences from wild type mice were less than 2-fold(Supplementary Fig. S4a). However, at 3 weeks after birth, when Ltbp2/4S DKO mice showed partial lethality(Fig. 2), the expression levels of Eln and Fbn2 were increased about 10-fold and 3-fold, respectively, in Ltbp2/4S
DKO mouse lungs, compared with that of wild type lungs (Supplementary Fig. S4b). The increase in Fbn1 and Lox
expression in Ltbp2/4S DKO tissues was not statistically significant, but these data indicate compensatory expression of Eln but no notable increase in elastolytic metalloproteases. These findings suggested that disruption ofelastic fibers was primarily caused by defects in elastic fiber formation in Ltbp2/4S DKO lung tissues at this stage,
rather than by degradation of elastic fibers. At 8 weeks after birth, which is the period when surviving Ltbp2/S
DKO mice develop advanced-stage emphysema, Eln expression approached the normal level, and expression ofother elastogenic genes, including Fn1, Fbn1, Fbn2, Fbln4, Fbln5, and Lox was dramatically decreased, whereas
the expression level of Mmp12 (macrophage elastase) was increased nearly 3-fold (Supplementary Fig. S4c). These
data suggest that elastic fiber-producing mesenchymal cells were impaired and that the MMP-12 produced bymacrophages further degraded elastic fibers in Ltbp2/4S DKO mouse lung tissues at this stage.

Either LTBP-2 or -4 is necessary for microfibril formation in serum-free culture of mouse embryonic fibroblasts. To test the hypothesis that LTBP-4 compensates for the loss of LTBP-2 in microfibril for-mation, we analyzed microfibril formation in vitro using cultured mouse embryonic fibroblasts (MEFs) obtained
from mutant mouse embryos. MEFs were cultured in serum-free media for 4 days and immunostained with
anti-fibrillin-1 (for microfibril formation) as well as anti-LTBP-2 and -4 antibodies. Wild type MEFs produced
a fibrillin-1–positive microfibril meshwork on the cells, and Ltbp2 null MEFs and Ltbp4S null MEFs showedslightly reduced signals by anti-fibrillin-1 antibody staining (Fig. 5a–c). Notably, microfibril meshwork formation was significantly abrogated in Ltbp2/4S DKO MEFs (Fig. 5d, and Supplementary Fig. S5a), but was rescuedby the addition of either 5 nM of recombinant LTBP-2 or -4S (Fig. 5E,F, and Supplementary Fig. S5a). mRNA
expression of Fbn1 and Fbn2 was even increased in Ltbp2/4S DKO MEFs by 2-fold compared to WT MEFs

Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

4

www.nature.com/scientificreports/

Figure 4. Histological analysis of Ltbp2/4S mutant mouse lungs. (a) Lung sections of mice at embryonic day
18.5 (E18.5) were stained with hematoxylin and eosin. Bars: 400 μ​m. (b) Lung sections of 8-week-old mice were
stained with hematoxylin and eosin. Bars: 100 μ​m. The terminal air sac enlargement in the lungs of Ltbp2/4S
DKO mice was more severe than that observed in the lungs of Ltbp4S−/− mice. (c) Electron micrographs ofelastic fibers stained black by tannic acid in the lungs of 8-week-old mice. The elastic fibers of Ltbp4S−/− andLtbp2/4S DKO lungs were disorganized. Note bare microfibril bundles (open arrow) and elastin deposits outside
microfibrils (closed arrow) in Ltbp4S−/− lung tissues. In Ltbp2/4S DKO lung tissues, bare microfibril bundles
were not observed, and elastic fibers were more severely fragmented. Bars: 1 μ​m. (d) Distribution of microfibrils
in the lungs of 8-week-old mice. Cryosections of mouse lungs were stained with a rabbit anti-fibrillin-1
antibody and visualized using an Alexa-488-labeled anti-rabbit IgG antibody. Nuclei were stained with Hoechst
33258. Bars: 50 μ​m.

(Supplementary Fig. S5b). These data indicate that either LTBP-2 or LTBP-4S is required for fibrillin-positive
microfibril meshwork formation under serum-free conditions. However, microfibril meshwork formation
was indistinguishable between the genotypes when cells were cultured in 3% serum-containing medium(Supplementary Fig. S6), suggesting that an unknown element(s) contained in fetal bovine serum promoted
microfibril formation without a requirement for endogenous LTBPs. In contrast, elastin deposition onto microfibrils, which was visualized by immunostaining with anti-elastin and anti-fibulin-5 antibodies after cells were
cultured in 10% serum-containing media for 14 days, strictly depended on the presence of LTBP-4S protein, withor without LTBP-2 (Supplementary Figs S7 and S8).

Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

5

www.nature.com/scientificreports/

Figure 5. Microfibril formation on cultured MEFs from mutant mice. MEFs of all genotypes were cultured
in serum-free media for four days, and the ECM was stained with anti-fibrillin-1, anti-LTBP-2, and anti-LTBP-4
antibodies, followed by fluorophore-labeled secondary antibodies corresponding to each first antibody (green
for fibrillin-1, white for LTBP-2, and red for LTBP-4). Nuclei were stained with Hoechst 33258. MEFs lacking
either LTBP-2 (b) or LTBP-4S (c) produced a weak but clear fibrillin-1 meshwork as observed in wild type MEFs(a), whereas MEFs lacking both LTBP-2 and LTBP-4S only produced aggregated deposition but no fibrous
fibrillin-1–positive meshwork (d). Supplementation of recombinant protein of LTBP-2 (e) or LTBP-4S (f) at aconcentration of 5 nM into the cultured medium restored microfibril meshwork formation on Ltbp2/4S DKO
MEFs. Bars: 150 μ​m.

Disruption of ciliary zonules in Ltbp2 null mice was compensated by ectopic LTBP-4 overexpression. Next, we overexpressed LTBP-4 in the eyes of mice with an Ltbp2 null background, to assess whether

LTBP-4 could compensate for the loss of LTBP-2 in vivo. Knock-in mice that had a CAG-promoter-driven Ltbp4S
cDNA at the Rosa26 locus displayed enhanced expression of Ltbp4S in the whole body, and survived to adulthood
without any gross malformation (Supplementary Fig. S9). These mice were crossed with Ltbp2 null mice to obtain
Ltbp2 null; Ltbp4S KI mice. Without the Ltbp4S knock-in allele, eyes from 4-week-old Ltbp2 null mice exhibited
fragmented ciliary zonules (Fig. 6a,b). However, the zonules were partially restored by the presence of ectopically
expressed LTBP-4S in the eyes of Ltbp2 null; Ltbp4S KI mice (Fig. 6c), while LTBP-4S protein co-localized withthe fibrillin-1 present in ciliary zonule microfibrils. These data indicated that LTBP-2 and -4 have an overlapping
functions in forming the robust architecture of ciliary zonules in vivo.

Discussion

The storage of TGF-β​in a latent form in the extracellular space is one of the major functions of LTBPs. However,
LTBP-2 and -4 also have TGF-β​-independent roles, as LTBP-2 does not bind TGF-β​, and only small proportion of
LTBP-4 binds TGF-β​4,5,23. We and others have reported such TGF-β​-independent functions of LTBPs, especiallyin the development of microfibrils and elastic fibers. LTBP-2 deficiency causes lens luxation due to ciliary zonule
fragmentation in humans and mice, suggesting that the function of LTBP-2 is associated with the formationof the robust structure of ciliary zonules consisting of fibrillin-microfibrils13. Although LTBP-2 is expressed intissues other than the eyes that are abundant in microfibrils and elastic fibers, such as the lungs and arteries15,16,
the function of LTBP-2 in these tissues has not been defined, as LTBP-2 deficiency only affected the eyes. On theother hand, we reported that LTBP-4 promotes deposition of elastin onto microfibrils in a TGF-β​-independent
manner, which is a critical step in elastic fiber assembly, whereas no role of LTBP-4 in microfibril formation has
been deteremined19. In the current study, we determined that LTBP-2 and LTBP-4 have overlapping functions
that enable the production of stable microfibril structures in vitro and in vivo.
Ltbp4S null mice develop pulmonary emphysema and cardiomyopathy18. The life span of Ltbp4S null mice isvariable. Sterner-Kock et al. reported that the homozygous mutant mice survived until 6 months of age18, whereas
Dabovic et al. reported a lethality rate of about 30% in homozygous mice by 21 days after birth20. In our study,
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

6

www.nature.com/scientificreports/

Figure 6. Restoration of ciliary zonule formation in Ltbp2−/−; Ltbp4S KI mice. Ltbp4S KI mice ubiquitously
expressed LTBP-4S in the whole body, including ciliary bodies, whereas LTBP-4 was not expressed in ciliary
bodies of wild type mice. By crossing these mice with Ltbp2−/− mice, Ltbp2−/−; Ltbp4S KI mice were produced,
and ciliary zonule formation of the mouse eyes was visualized using immunofluorescent analysis, as in Fig. 5.
LTBP-2 and fibrillin-1 co-localized on ciliary zonules of wild type mouse eyes, but fibrous fibrillin-1 staining
was largely absent in the Ltbp2−/− eye. Ectopic expression of LTBP-4 in ciliary bodies restored ciliary zonule
formation in Ltbp2−/−; Ltbp4S KI mouse eyes. Bars: 100 μ​m.

Ltbp4S null homozygous mice did not show lethality by at least 4 weeks after birth, consistent with the previous
report from 200218. This variation in the survival rate may be due to the different genetic background of themutant mice.
Whereas Ltbp2 null mice and Ltbp4S null mice did not exhibit increased lethality by 4 weeks after birth,
approximately half of the Ltbp2/4S DKO mice died at this time point. A more severe form of emphysema than thatin Ltbp4S null mice was the only critical phenotype we observed that could affect the life span of Ltbp2/4S DKO
mice. Elastic fibers in the lungs of Ltbp2/4S DKO mice were markedly fragmented, which could account for thesevere emphysema observed. Because elastic fibers are composed of microfibrils and elastin, and expression of the
Eln gene was upregulated in the lungs of 3-week-old Ltbp2/4S DKO mice, defects in elastic fibers in these tissues
were attributed to defects in microfibrils and/or elastin assembly onto microfibrils. Microfibril bundles without
elastin deposition were observed in Ltbp4S null mice, as previously reported21, which is indicative of defective
elastin deposition onto microfibrils. The absence of such bare microfibril bundles in Ltbp2/4S DKO lungs suggests that the microfibril structure itself was affected in these tissues (Fig. 4c). The fragmented fibrillin-1 staining
pattern observed in the lungs of Ltbp2/4S DKO mice supports this notion (Fig. 4d). We observed elevated Mmp12
gene expression in the lungs of surviving 8-week-old Ltbp2/4S DKO mice, which could have been caused bychemotactic function of fragmented elastic fibers. At this advanced stage, degradation of elastic fibers by MMP-12
was considered to additively contribute to further impairment in elastic fibers in these tissues.
Another possible explanation is that LTBP-2 and -4 may be protecting microfibrils from enzymatic degradation, rather than forming microfibrils. Further examinations such as time-course of fibrillin-1 immunostainingof lungs and protease resistance assay of microfibrils would elucidate the molecular function of LTBP-2 and -4.
Mutations in the FBN1 gene cause Marfan syndrome, one of the major symptoms of which is aortic aneurysm24. Because fibrillin-1 is the main component of microfibrils, we reasoned that microfibril defects in Ltbp2/4S
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

7

www.nature.com/scientificreports/
DKO mice could cause aneurysms, which turned out not to be the case. One possibility is that the architecture of
microfibrils differs between tissues, and the microfibril architecture in arteries does not require LTBP-2 and -4.
Elastic fibers in arteries form a unique structure called elastic lamellae. Therefore, microfibrils that provide scaffolds for elastin deposition could also form a lamellar meshwork that is different from microfibril structures
found in the eyes and lungs. Another possible explanation is that aneurysms in Marfan syndrome are caused bya disturbance of signaling maintained by fibrillin-1, and not by defects in microfibril structure per se. It has beenreported that antagonizing TGF-β​signaling or angiotensin II signaling suppresses the development of aneurysms
in Fbn1 mutant mice or Marfan syndrome patients, even though these drugs does not correct the structural problems in microfibrils caused by mutant fibrillin-125.
Culturing of MEFs required LTBP-2 or -4 for the development of a microfibril meshwork in the absence of
fetal bovine serum, although neither of these was necessary for microfibril formation in the presence of serum.
These data suggest that circulating LTBP-2, -4, or unknown factors in the serum promoted microfibril formationin the absence of endogenous LTBP-2 and -4. Further study is necessary to identify such circulating factors thatfacilitate microfibril development.
Ectopically overexpressed LTBP-4 rescued the ciliary zonule phenotype in Ltbp2 null mice. In Ltbp2 null
mice, ciliary zonule microfibrils developed when the mice were born, but were fragmented after birth, indicating an unstable microfibril structure. We reported an absence of a thick bundle structure of microfibrils in thezonules of these mice, which suggests that LTBP-2 is necessary for the secondary structure of microfibrils in
ciliary zonules13. The current data demonstrate that LTBP-4 has a similar function.
It has been reported that enhanced TGF-β​2 signaling contributes to the lung septation defect in Ltbp4S nullmice. Ltbp4S/Tgfb2 DKO mice were shown to have a lessened lung septation defect than that in Ltbp4S nullmice at E18.5, although elastic fiber impairment was not rescued in the Ltbp4S/Tgfb2 DKO mice 21. Although
LTBP-2 does not bind TGF-β​, and the lung septation defect in Ltbp4S null mice at E18.5 was not obvious in our
experiments (Fig. 4a), it is possible that the severe emphysematous phenotype in Ltbp2/4S DKO mice may also beaffected by increased TGF-β​signaling. Further study is necessary to examine the role of TGF-β​signaling in thepathogenesis of the emphysema present in Ltbp2/4S DKO mice.
In summary, we have demonstrated that LTBP-2 and -4 have an overlapping functions in the development of
stable microfibril structure in vivo in the lungs, eyes, and in vitro in MEFs. In ciliary bodies, where LTBP-4 was
scarcely expressed, Ltbp2 deficiency was sufficient to cause disruption of ciliary zonule microfibrils, which wascompensated by ectopically overexpressed LTBP-4. Compensation of the microfibril meshwork formation in
Ltbp2/4S DKO MEFs culture by recombinant LTBP-2 or -4, together with the electron microscopic analyses ofmutant lungs also support this notion. Further investigation will elucidate the specific role of LTBP-2 and -4 in thedevelopment and organization of microfibril bundle architecture.

Materials and Methods
Mice.

All mice used in this study were maintained on normal laboratory diet. Ltbp2−/− mice were generated
with C57BL6/J ES cells and kept in pure C57BL6/J background as previously described13. Ltbp4S−/− mice18 were
backcrossed to C57BL6/J more than 10 times before experiments. Ltbp4S KI mice, which contain CAG promoter-driven Ltbp4S cDNA in the Rosa26 locus (Supplementary Fig. S9), were generated using C57BL6/J ES cells
for homologous recombination, and maintained in C57BL6/J background. All procedures were approved by theCommittee for Animal Experiments at Kansai Medical University, and conducted according to the Guideline forAnimal Experimentation at Kansai Medical University.

Antibodies and Immunodetection.

Primary antibodies used were: chicken anti-LTBP-2 polyclonal(1:100, made by immunizing chickens with recombinant mouse LTBP-2, Figs 5 and 6, Supplementary Figs S6,S7 and S8), goat anti-LTBP-4 polyclonal (1:100; R&D Systems, Figs 5 and 6, Supplementary Figs S6, S7 and S8),
rabbit anti-mouse fibrillin-1 polyclonal (1:100, previously described13, Figs 4–6, Supplementary Fig. S6), rabbit
anti-elastin polyclonal PR385 (1:100; Elastin Products Company), and mouse anti-fibulin-5 monoclonal 10A(1:100, previously described26, Supplementary Fig. S8). Secondary antibodies conjugated with Alexa 488, 546
and Dylight 650 were purchased from Thermo Fisher Scientific (Alexa 488 and 546) and Leinco Technologies(Dylight 650). Frozen sections were fixed with acetone at −​20 °C for 5 min, blocked with PBS containing 1%
bovine serum albumin and 0.05% Triton X-100 before immunofluorescent staining. Immunofluorescence images
were obtained using all-in-one fluorescence microscope BZ-9000 (Keyence).

Cell Culture. MEFs were maintained in DMEM (Thermo Fisher Scientific) supplemented with 2 mM glutamine, 100 units/100 μg​ ·mL−1 penicillin/streptomycin, and 10% FBS at 37 °C in 5% CO2. For microfibril analyses,
MEFs were cultured on coverslips in DMEM/F12 (Thermo Fisher Scientific) supplemented with 2 mM glutamine,
100 units/100 μ​g·mL−1 penicillin/streptomycin, 1x ITS-X (Thermo Fisher Scientific) with or without 3% FBS at
37 °C in 5% CO2 for 4 days, followed by fixation with cold methanol and immunostaining. For elastic fiber analyses, 10% FBS instead of ITS-X was used and culture period was extended to 14 days.
Protein Purification.

Purification of recombinant LTBP-2 and -4S with a FLAG and a 6x His tag was
described previously19,26. Briefly, these proteins were purified using TALON affinity resin (Takara) fromserum-free conditioned medium of 293T cells stably transfected with pEF6/FLAG-LTBP-2 or -4S.

Electron Microscopy.

Lung samples were fixed with 2% paraformaldehyde, 2% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.4) at 4 °C overnight. The samples were additionally stained with 1% tannic acid in 0.1 M
cacodylate buffer 1 hour, followed by wash and post-fixation with 2% osmium tetroxide in 0.1 M cacodylate buffer.
The samples were embedded in resin Quetol-812 (Nisshin EM). Ultra-thin sections were stained with 2% uranyl

Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

8

www.nature.com/scientificreports/
acetate and lead stain solution (Sigma-Aldrich), and were observed with transmission electron microscope JEM1400plus (JEOL Ltd.).

RT-PCR and qPCR.

Total RNA from tissues and MEFs was extracted using TRIzol reagent (Thermo Fisher
Scientific) and RNeasy kit (Qiagen), respectively, and transcribed to cDNA with random hexamers using
SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). RT-PCR was performed using the primers indicated in Supplementary Table S1. For qPCR, the reaction was performed with QuantiFast SYBR GreenPCR Kit (Qiagen), and the products were analyzed with Rotor-Gene Q (Qiagen). The primer sequences used for
qPCR are shown in Supplementary Table S2.

Quantification of microfibrils produced by MEFs.

MEFs cultured on 96-well optical bottom plate(Thermo Fisher Scientific) were fixed with cold methanol and reacted with anti-fibrillin-1 antibody, followed bystaining with Alexa 488-conjugated secondary antibody and Hoechst nuclear dye. The amount of immunostained
microfibrils and cell numbers were measured with Cellomics ArrayScan VTI system (Thermo Fisher Scientific).

Statistics. Statistical analysis of survival rate was performed by log-rank test. Statistical analyses of qPCR,
quantification of microfibrils, and physical characteristics were performed by one-way ANOVA with Dunnett’s
post hoc test. P <​ 0.05 compared to WT was considered significant.

References

1. Ramirez, F., Sakai, L. Y., Dietz, H. C. & Rifkin, D. B. Fibrillin microfibrils: multipurpose extracellular networks in organismal
physiology. Physiol Genomics 19, 151–154 (2004).
2. Kielty, C. M., Sherratt, M. J., Marson, A. & Baldock, C. Fibrillin microfibrils. Adv Protein Chem 70, 405–436 (2005).
3. Kielty, C. M., Sherratt, M. J. & Shuttleworth, C. A. Elastic fibres. J Cell Sci 115, 2817–2828 (2002).
4. Koli, K., Saharinen, J., Hyytiäinen, M., Penttinen, C. & Keski-Oja, J. Latency, activation, and binding proteins of TGF-beta. Microsc
Res Tech 52, 354–362 (2001).
5. Rifkin, D. B. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol
Chem 280, 7409–7412 (2005).
6. Robertson, I. B. et al. Latent TGF-β​-binding proteins. Matrix Biol 47, 44–53 (2015).
7. Ali, M. et al. Null mutations in LTBP2 cause primary congenital glaucoma. Am J Hum Genet 84, 664–671 (2009).
8. Narooie-Nejad, M. et al. Loss of function mutations in the gene encoding latent transforming growth factor beta binding protein 2,
LTBP2, cause primary congenital glaucoma. Hum Mol Genet 18, 3969–3977 (2009).
9. Azmanov, D. N. et al. LTBP2 and CYP1B1 mutations and associated ocular phenotypes in the Roma/Gypsy founder population. Eur
J Hum Genet 19, 326–333 (2011).
10. Désir, J. et al. LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary
glaucoma. Eur J Hum Genet 18, 761–767 (2010).
11. Kumar, A. et al. A homozygous mutation in LTBP2 causes isolated microspherophakia. Hum Genet 128, 365–371 (2010).
12. Khan, A. O., Aldahmesh, M. A. & Alkuraya, F. S. Congenital megalocornea with zonular weakness and childhood lens-related
secondary glaucoma - a distinct phenotype caused by recessive LTBP2 mutations. Mol Vis 17, 2570–2579 (2011).
13. Inoue, T. et al. Latent TGF-β​binding protein-2 is essential for the development of ciliary zonule microfibrils. Hum Mol Genet 23,
5672–5682 (2014).
14. Gibson, M. A. et al. Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue
isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol 15, 6932–6942 (1995).
15. Shipley, J. M. et al. Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement earlyin mouse development. Mol Cell Biol 20, 4879–4887 (2000).
16. Hirai, M. et al. Latent TGF-beta-binding protein 2 binds to DANCE/fibulin-5 and regulates elastic fiber assembly. EMBO J 26,
3283–3295 (2007).
17. Urban, Z. et al. Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, anddermal development. Am J Hum Genet 85, 593–605 (2009).
18. Sterner-Kock, A. et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4)
causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 16, 2264–2273 (2002).
19. Noda, K. et al. Latent TGF-β​binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc Natl Acad Sci USA
110, 2852–2857 (2013).
20. Dabovic, B. et al. Control of lung development by latent TGF-β​binding proteins. J Cell Physiol 226, 1499–1509 (2011).
21. Dabovic, B. et al. Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta
activity. J Cell Physiol 219, 14–22 (2009).
22. Shifren, A. & Mecham, R. P. The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc Am Thorac Soc 3, 428–433(2006).
23. Todorovic, V. & Rifkin, D. B. LTBPs, more than just an escort service. J Cell Biochem 113, 410–418 (2012).
24. Ramirez, F. & Dietz, H. C. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17, 252–258(2007).
25. Matt, P. et al. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac
Cardiovasc Surg 135, 389–394 (2008).
26. Hirai, M. et al. Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo. J Cell Biol
176, 1061–1071 (2007).

Acknowledgements

We thank Ms. M. Masuda for technical assistance. This work was supported by NEXT Program in Japan (T.N.),
Japan Society for the Promotion of Science (T.N. and T.O.A.), and Takeda Science Foundation (T.N.).

Author Contributions

Y.F. and T.N. designed research; Y.F., H.Y., T. Inoue, T.O. and K.N. performed research; H.v.M. contributed new
reagents; Y.F., T. Iwasaka, I.S. and T.N. analyzed data; and Y.F., T.O.A. and T.N. wrote the main manuscript text.
All authors reviewed the manuscript.

Additional Information

Supplementary information accompanies this paper at http://www.nature.com/srep
Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

9www.nature.com/scientificreports/
Competing Interests: The authors declare no competing financial interests.
How to cite this article: Fujikawa, Y. et al. Latent TGF-β binding protein 2 and 4 have essential overlapping
functions in microfibril development. Sci. Rep. 7, 43714; doi: 10.1038/srep43714 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps andinstitutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images
or other third party material in this article are included in the article’s Creative Commons license,
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material. To view a copy of thislicense, visit http://creativecommons.org/licenses/by/4.0/© The Author(s) 2017

Scientific Reports | 7:43714 | DOI: 10.1038/srep43714

10